Renjith Vijayakumar Selvarani/LinkedIn
Oct 12, 2025, 15:39
Renjith Vijayakumar Selvarani: A Heart Attack Isn’t Just a Health Scare — It’s a Medical Emergency
Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post on LinkedIn:
“Heart Attack — Every Second Counts
A heart attack isn’t just a health scare — it’s a medical emergency. Immediate action can save a life.
- First Goal: Restore blood flow to the heart as fast as possible.
- In emergency care, doctors use:
- Aspirin – prevents further clotting
- Thrombolytics – dissolve existing clots
- Nitroglycerin – improves heart blood flow
- Pain relievers – ease discomfort during crisis
- In hospitals, life‑saving procedures may include:
- Angioplasty with stent placement – reopens blocked arteries
- Coronary artery bypass surgery – creates an alternate route for blood flow
- Long-term care is just as important:
- Healthy lifestyle changes – exercise, balanced diet, stress management
- Regular medicines – beta‑blockers, statins, blood thinners
- Cardiac rehabilitation – strengthens recovery and lowers future risk
- Remember: The faster the treatment, the better the outcome. Awareness can turn fear into action — and action into life saved.”
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp